Despite concerns raised by clinicians and ethicists, direct-to-consumer testing for Alzheimer’s disease biomarkers is here, ...

Quest Diagnostics has signed up to offer a blood test that can help diagnose Alzheimer’s disease, following its FDA clearance earlier this year. | The Lumipulse G blood test measures the ratio between ...

Quest will offer the first FDA-approved blood test to help detect Alzheimer’s-related amyloid pathology in patients with ...

Jim Rogers, who lives in Australia, was diagnosed with early-onset Alzheimer's at 55 years old after the seconds-long test ...

After witnessing my mum's cognitive decline and with dementia now the leading cause of death for Australian women, I can't ...

Of the 258 participants, 195 were cognitively asymptomatic, 34 had mild cognitive impairment, 23 had dementia, and six had an ...

The blood test is significantly less expensive and invasive than other tests for diagnosing Alzheimer's, opening the door for early interventions.

In patients showing cognitive decline, a new blood test for Alzheimer's is expected to make diagnosis more convenient, accessible and inexpensive than other existing tests.

US researchers say their next step is to extend the test to a wider range of patients, including those with early Alzheimer's who do not have any cognitive symptoms.

The lumipulse blood test brings renewed hope for earlier diagnosis and treatment for millions of people facing the uncertainty of Alzheimer's disease and other dementias.

The first Alzheimer's blood test cleared by the Food And Drug Administration is poised to change the way doctors diagnose and treat the disease.

The test may make it easier to identify whether people with memory and thinking problems have Alzheimer’s or not.